Gastro Flashcards

1
Q

What is the most likely culture growing in an alcohol patient with ascitic fluid?

A

E. Coli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why are all patients with Coeliac offered the pneumococcal vaccine?

A

They often have a degree of hyposplenism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Management of hepatic encephalopathy

A
  1. Treat underlying precipitants (e.g. infection, GI bleed, constipation, drugs (sedatives, diureticvs, hypokalaemia)
  2. Lactulose - thought to increase excretion of ammonia (± rifaxamin for secondary prophylaxis)
  3. Consider embolisation of portosystemic shunts and liver transplant in some patients.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Tumour marker for hepatocellular carcinoma?

A

AFP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Gilbert’s syndrome - management

A

Conservative - no treatment required (bilirubin tends to be transient rise due to deficiency in glucoronyl transferase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Screening tool used for malnutrition

A

MUST score (malnutrition universal screen tool) - determines low, medium and high risk patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the recommended drug for prophylaxis of variceal bleeding?

A

Non-cardiac selective beta blocker, e.g. propranolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Vitamin deficiency caused by Crohn’s and why?

A

B12 as it affects terminal ileum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Management of hepatorenal syndrome

A
  1. Vasopressin analogues, for example terlipressin, have a growing evidence base supporting their use. They work by causing vasoconstriction of the splanchnic circulation
    volume expansion with 20% albumin
    transjugular intrahepatic portosystemic shunt
  2. Volume expansion with 20% albumin
  3. Transjugular intrahepatic portosystemic shunt
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Classificiation of inflammatory bowel disease (mild, moderate and severe)

A
  1. Mild - systemically well, <4 stools per day
  2. Moderate - systemically well, >4 stools per day
  3. Severe - systemically UNWELL, >6 stools per day
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What advice should be given to patients undergoing OGD regarding their PPI or H2 receptor antagonist?

A

Stop at least 2 weeks prior to endoscopy as it can mask serious underlying pathology, e.g. gastric cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hiatus hernia classification (x2)

A
  1. Sliding (80%) - LOS slides through the oesophageal hiatus; acid reflux common
  2. Rolling (20%) - LOS remains in the abdomen but the fundus herniates through the diaphragm; GORD is less common as LOS is intact
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

2 ways gastric cancer may be staged - which one has been shown to be more superior?

A

CT or endoscopic USS can be done; USS shown to be more superior

CT CAP needs to be doneas first line + laparoscopy to identify occult peritoneal disease ± PET CT (particularly for junctional tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Management of gastric carcinoma

A
  1. Disease >5-10cm from OG junction - Mx with subtotal gastrectomy - inferior stomach joined with jejunum
  2. Total gastrectomy - tumour <5cm from OG junction (proximal disease)
  3. Oesophagogastrectomy if extends to oesophagus
  4. If confined to mucosa - endoscopic submucosal resection
  5. Other interventions:
    - Lymphadenectomy
    - Chemotherapy pre- or post-operatively
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Diagnosis for Zollinger-Ellison syndrome

A

Fastin gastrin levels - single best screen test

Secretin stimulation test may also be done

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Primary biliary cirrhosis - antibody

A

Anti-mitochondrial antibody

17
Q

Management of acute cholecystitis

A
  1. NMB, carefully monitor
  2. Medical - analgesia, IV fluids, antibiotics
  3. Surgical - cholecystectomy ideally within 48h of presentation
18
Q

Ascending cholangitis - clinical features

A
  1. Charcot’s triad (20-50%) - RUQ pain, fever, jaundice

2. Hypotension and confusion

19
Q

Management of ascending cholangitis

A
  1. IV antibiotics

2. ERCP after 24-48h to relieve any obstruction

20
Q

Primary sclerosing cholangitis is associated with what inflammatory bowel disease?

What malignancy does it carry an increased risk of?

A

Ulcerative colitis

Cholangiocarcinoma (and colorectal cancer)

21
Q

Prognosis of liver cirrhosis can be quantified with what scoring system

A

Child-Pugh classification

22
Q

Acute management of variceal haemorrhage

A
  1. ABCDE - resuscitate first before endoscopy
  2. Endoscopic variceal band ligation (1st choice); or endoscopic sclerotherapy
  3. Terlipressin
  4. Sengstaken-Blakemore tube
  5. Transjugular intrahepatic portosystemic shunt (TIPS)
  6. IV antibiotics - quinolones
  7. Correct clotting - FFP, vitamin K
23
Q

Prophylaxis of variceal bleed

A
  1. Propanolol - helps decrease re-bleeding and mortality (may be given to pts w/ varices who have never had an acute bleed)
  2. Endoscopic variceal band ligation + PPI - do every 2 weeks until all varices eradicated
24
Q

Management of ascites caused by portal HTN

A
  1. Dietary sodium restriction
  2. Oral spironolactone (large dose)
  3. Furosemide - aim to lose 0.5kg/day; do not do diuresis too fast - inc. encephalopathy risk
  4. Paracentesis - for medication resistant; Rx with IV albumin infusion to inc. circulating volume
  5. TIPS if above fails
25
Q

Management of hepatitis B infection

A

pegylated interferon-alpha - reduces viral replication by 30%

26
Q

Hepatitis B in pregnancy

A

All women are offered vaccination in pregnancy

If baby born with mum acquired HBV in pregnancy/chronically infected = complete vaccination course + Hep B immunoglobulin

27
Q

Hep B markers present in:

  1. Previous immunisation
  2. Previous HBV (>6m), now NOT carrier
  3. Previous HBV, now is a carrier
A
  1. anti-HBs
  2. anti-HBc (IgG), anti-HBs
  3. anti-HBc, HBsAg
28
Q

Metabolic consequences of re-feeding syndrome

A

hypophosphataemia
hypokalaemia
hypomagnesaemia
abnormal fluid balance